Project alters rules to incorporate technologies into SUS

A bill in the Chamber of Deputies wants to change the way new medicines, products and procedures are evaluated to enter the Unified Health System (SUS). PL 1.738/2026 amends the Organic Health Law to divide the process into two stages: a scientific and an economic one.

Currently, the National Commission for the Incorporation of Technologies in the SUS (Conitec) conducts the two analyses simultaneously. The proposal, presented by MEPs Silvia Cristina (PP-RO) and Geraldo Resende (PSDB-MS), aims to give more clarity to the process and allow adjustments before the final decision.

How Assessment Works Today

Today, Conitec analyzes both the effectiveness of the product and its cost to the public system. This means that a technology can be reproved for economic reasons without the applicant having a chance to adjust the price or present new data.

In practice, the commission evaluates whether the drug or procedure works, whether it is safe and whether it is financially worthwhile for the SUS. The proposed change separates these steps, creating a more transparent flow.

https://www.youtube.com/watch?v=0TbwtmxAaMs

Video: YouTube | Source: www.poder360.com.br

What changes with the project

The text will be evaluated in two phases. The first is scientific and clinical, which analyzes the effectiveness, effectiveness and safety of technology. The second is the economic one, which compares the costs of innovation with the options already available in the public network.

This separation, according to the authors, allows the applicant to adjust parameters such as price to improve the cost-effectiveness ratio before the final decision. The idea is to prevent good technologies from being discarded just for starting price issues.

Justification of the authors

In the justification of the project, the MEPs state that the phase-out gives greater clarity on the main obstacles to incorporation. “The phased approach gives greater clarity on the main obstacles to the incorporation of the evaluated technologies, allowing the applicant to adjust economic parameters, such as price, to improve the cost-effectiveness ratio and benefit the patient,” the text says.

For them, the change brings transparency and rationality to public spending. The proposal does not change the evaluation criteria, only reorganizes the process into distinct stages.

Processing in Congress

The draft is conclusive and will be analyzed by the committees of Health; and Constitution and Justice and Citizenship of the Chamber of Deputies. To become law, it needs to be approved by the House and Senate.

If approved, the proposal will enter into force 180 days after publication. There is no set date for voting in committees.

Impact for the SUS

The separation of the stages can give more predictability for companies and managers. The applicant will have the chance to correct the price or submit new economic data before the final decision, which may increase the chances of incorporating cost-effective technologies.

On the other hand, the process may take longer, since the phases will be sequential. The source did not detail whether there will be specific deadlines for each stage.

This text was originally published by the House Agency on October 27, 2026. The content is free for republication, cited the source, and has been adapted to the Power360 standard.

Read Also

House debates mixed district system to elect deputies

Right without Bolsonaro is opportunism, says Gilson Machado

Kassab charges economic measures for PSD to support Lula

Font

www.power360.com

Prioritize Power in Google (www.google.com)

Organic Law of Health (www2.camara.gov.br)

Learn more about the processing of bills. (www.camara.leg.br)

published (www.camara.leg.br)

Power360 integrates the (thetrustproject.org)